Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 117,140 |
|
|||||
| News | - | ||||||
| Day High | 0.9639 | Low High |
|||||
| Day Low | 0.883501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Monopar Therapeutics Inc | MNPR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0856 | 9.36% | 0.9999 | 00:00:04 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.959 | 0.883501 | 0.9639 | 0.94 | 0.9143 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 353 | 117,140 | $ 0.9402736 | $ 110,144 | - | 0.2739 - 1.73 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:38:21 | 1 | $ 0.9999 | USD |
Monopar Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.83M | 14.87M | - | 0 | -8.4M | -0.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Monopar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MNPR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.847 | 1.08 | 0.75 | 0.8675057 | 208,254 | 0.1529 | 18.05% |
| 1 Month | 0.61 | 1.08 | 0.5861 | 0.818036 | 183,350 | 0.3899 | 63.92% |
| 3 Months | 0.70 | 1.08 | 0.4999 | 0.7453425 | 142,860 | 0.2999 | 42.84% |
| 6 Months | 0.3182 | 1.73 | 0.28 | 0.9925495 | 2,813,349 | 0.6817 | 214.24% |
| 1 Year | 0.92 | 1.73 | 0.2739 | 0.9225144 | 1,713,453 | 0.0799 | 8.68% |
| 3 Years | 6.24 | 6.98 | 0.2739 | 1.02 | 608,670 | -5.24 | -83.98% |
| 5 Years | 24.14 | 48.00 | 0.2739 | 1.62 | 437,653 | -23.14 | -95.86% |
Monopar Therapeutics Description
| Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. |
